Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemolizumab Phase 2 in Atopic Dermatitis
NCT01986933Phase 2Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Nov 2013
- Primary completion
- Apr 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nemolizumab in atopic dermatitis (AD), sponsored by Chugai Pharmaceutical Co., Ltd.. Started Nov 2013; status: completed.
02
Drugs
nemolizumab
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01986933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986933.